Not Losing Weight on Semaglutide: Common Reasons and What to Do

Weight loss on semaglutide typically appears in stages, not as a steady weekly drop — early weeks often show little movement on the scales even when the medicine is working.
The maintenance dose matters: most trial evidence for Wegovy was measured at 2.4mg (and now 7.2mg), not at the 0.25mg or 0.5mg starting doses.
Dietary habits, protein intake, sleep and activity all interact directly with how much weight semaglutide helps you lose.
If weight loss has stalled after reaching your maintenance dose, a prescriber should review whether your dose, your health picture or your approach to eating needs adjusting.

Semaglutide does produce meaningful weight loss for most people who take it, but it doesn't always happen quickly, and it doesn't always happen the way you'd expect. If you're not losing weight on semaglutide after several weeks, you are not alone — and in most cases there's a specific, fixable reason. The medicine is a prescription-only treatment that works best when the dose, your diet and your expectations are all properly calibrated by a clinician.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Why the scales may not be moving, and the steps to work through it

Step 1: Check where you actually are in the titration schedule

The first question to ask is simple and takes under a minute: look at the dose you're currently on. Wegovy starts at 0.25mg and steps up roughly every four weeks, 0.5mg, 1mg, 1.7mg, then 2.4mg. At the lower doses, appetite suppression is mild by design. The starting doses exist to let your body adjust, not to produce significant weight loss. How long Wegovy takes to work is closely tied to where you are in that schedule.

STEP 1, the pivotal semaglutide trial published in the New England Journal of Medicine, recorded around 15% average body-weight loss over 68 weeks at 2.4mg, the maintenance dose, not the starter doses. If you're on week four at 0.25mg and the scales haven't moved, that's expected. Give the titration time to reach therapeutic territory before concluding the medicine isn't working.

If you're already at or near 2.4mg and weight loss still isn't happening, that's a different conversation, and it's one worth having with your prescriber rather than adjusting anything yourself.

Step 2: Look honestly at what the medicine can and can't do alone

Semaglutide is licensed for weight management alongside a reduced-calorie diet and increased physical activity. Those words in the licence aren't a formality. The medicine reduces appetite significantly for most people, but it doesn't override the energy equation entirely.

A few things that quietly blunt the effect: eating very calorie-dense foods in smaller volumes (easy to do when portions feel smaller), low protein intake causing muscle loss alongside fat loss (which slows metabolism over time), poor sleep, and very high stress.

If you feel full sooner but have swapped to energy-dense snacks, or you're eating less but not adequately, you may be losing fat while retaining fluid or gaining lean mass, and the scales won't reflect that straightforwardly. The reasons Wegovy users sometimes see no movement on the scales often trace back to one of these practical factors rather than the medicine failing outright.

Your prescriber or a registered dietitian can help you structure intake around treatment; neither a forum nor a generic calorie app is a substitute for that. The NHS semaglutide page also outlines the lifestyle changes recommended alongside the medicine.

Step 3: Recognise a genuine plateau and know when it needs clinical attention

Plateaus are part of weight-loss biology. The body defends a set point, metabolism adapts and weight loss slows, sometimes to zero for weeks at a time. That's not unique to semaglutide. But there's a difference between a normal plateau and semaglutide not working for you at all.

A normal plateau: weight loss of 5–10% achieved, scales static for three to six weeks, no change in dose recently, lifestyle factors stable. These usually shift as the body recalibrates. An abnormal plateau: little or no weight change after six months at the highest tolerated dose. NICE guidance on semaglutide (Wegovy) notes that continuing treatment should be reviewed if less than 5% weight loss has occurred after six months on the maintenance dose.

If you're at that point, the right move is a clinical review. Why weight loss stops on semaglutide covers the biology of plateaus in more detail. For context on private treatment costs if you're considering your options, this comparison of Wegovy pricing in the UK is a useful reference.

Step 4: Consider whether early weeks deserve more patience

Some people find the first few weeks particularly discouraging. You're injecting weekly, managing side effects like nausea and fatigue, adjusting your eating, and the scales aren't moving. It feels counterproductive. Sticking through the titration phase is genuinely harder than it sounds.

Week-by-week expectations vary considerably between individuals. Some people find no change by week two perfectly normal; others worry at week six that something is wrong when the science says they're still in the build-up phase. The medicine's full effect on appetite and metabolism builds gradually as the dose increases.

What usually isn't helpful: changing your injection timing randomly, skipping doses because the scales haven't moved, or stopping without talking to your prescriber. All of those reset progress. Our Wegovy treatment overview explains the full schedule and what to expect at each stage, and our clinical team reviews every patient's progress before any repeat prescription is issued. If you have questions between doses, aftercare support is available seven days a week.

If you're thinking about starting treatment or reviewing whether semaglutide is right for you, check your eligibility through a free consultation, a prescriber will assess the full picture, not just the number on the scales.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions